Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

INSANE: Obesity news topic | Rare Historical Photos

Frequent Daytime Sleepiness Linked to Fatty Liver in U.S. Adults, Making It Worth Raising with Your Doctor

An ACG 2026 study tied daytime sleepiness and trouble sleeping to fatty liver in U.S. adults. Risk factors, simple liver tests, and when to speak up.

Medical Daily · 5h ago

Yes, obesity is a problem – but a greater one is the food industry and its greed

Letters: Ultra-processed foods are displacing traditional diets, warns Prof Kent Buse. Plus letters from Hugo Harper, Dr Pawan Randev and Patricia Hampton

The Guardian - UK · 12h ago

The Government Doesn't Know What's Best for You. Why Let It Decide What You Should Eat?

Governments are moving beyond mere advice and trying to regulate people's diets more directly.

Reason · Oct 12

From analysis to the latest developments in health,
read the most diverse news in one place.

The 10,000 Steps Rule Was Born From an Ad, Not a Study

Your phone buzzes in the evening: “You are 3,000 steps away from your goal.” So you pace around the room, walk up and down the corridor, or take one more round of the lane before bed, just to hit the magic number. Millions of people do this every day. But…

MyLifeXP · Oct 10

The Guardian view on cancers in under-50s: the risks of obesity must be confronted

Editorial: More research into the troubling rise in early onset cancers is needed. But we already know that food is among the culprits

The Guardian - UK · Oct 8

Dementia Patients Overweight or Obese at Diagnosis Had Up to 27% Lower Death Risk, Raising Caregiver Nutrition Questions

A national study of 4,523 U.S. adults with dementia linked higher weight at diagnosis to longer survival. Here is what it means for caregivers.

Medical Daily · Oct 8

WHO seeks more information from Russia on Irkutsk lab worker's death

Tedros Adhanom Ghebreyesus of WHO reported on a laboratory worker's death in Irkutsk due to severe pneumonia. Initial reports suggested a possible pneumonic plague infection following a lab accident. Russia's health authorities stated that no recent cases of plague were recorded in the area. An investigation and quarantine measures were…

The Economic Times · Oct 8

Read news from The Economist, FT, and more,
with one subscription

WHO's First Child Obesity Guidelines Advise Against Weight-Loss Drugs, Surgery and Devices for Children Under 10

WHO's first child obesity guidelines advise against weight-loss drugs and surgery under age 10. What the advice means for U.S. parents.

Medical Daily · Oct 7

Diabetes Drug Jardiance Cut a Heart-Linked Inflammation Marker Within Two Weeks in Small Vanderbilt Pilot of 16 Women

In a 16-woman Vanderbilt pilot, empagliflozin lowered blood-cell clumps tied to heart disease in two weeks. It does not change prescribing yet.

Medical Daily · Oct 7

WHO says medicines, surgery not first-line treatment for childhood obesity

The World Health Organization has released guidelines on treating obesity among children and adolescents. It emphasizes structured diets, physical activity, and behavioral changes as primary treatment methods. Weight-loss medications are not recommended for children aged zero to nine years. For adolescents, these medications may only be considered after conventional methods…

The Economic Times · Oct 7

Study reshaping how childhood obesity is identified

A study shows childhood obesity rates drop when using a new Lancet definition that focuses on actual health rather than just size, unlike Body Mass Index.

AAP · Oct 6

Experts give verdict on what under-50s need to do now to help avoid cancer as rates surge

Experts say the figures reflect the growing obesity epidemic, poor diets and insufficient exercise

The Independent UK · Oct 6

Hair Loss Was Just the Start? The Nail Truth

Hair shedding became one of the most talked-about cosmetic complaints linked with GLP-1 medicines. Now, researchers have found another change that is drawing attention: nail problems. A study presented at the 2026 European Academy of Dermatology and Venereology (EADV) Congress found that nail detachment was reported by 39% of GLP-1…

MyLifeXP · Oct 5

Postpartum GLP-1 Prescriptions Rose Nearly 24-Fold Among Privately Insured New Mothers, with Breastfeeding Safety Data Still Limited

A JAMA study of 1 million births found postpartum GLP-1 prescriptions rose nearly 24-fold. What new mothers should know about breastfeeding and cost.

Medical Daily · Oct 4

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily · Oct 3

Rhode Island Medicaid Ends Coverage of Wegovy, Zepbound, and Other GLP-1 Drugs Prescribed Only for Weight Loss

Rhode Island Medicaid stopped covering Wegovy, Zepbound, Saxenda, and Foundayo for weight loss on Oct. 1, 2026. Diabetes coverage continues. Here is what members should know.

Medical Daily · Oct 3

Liver Fat Fell to Normal in 23 of 26 Adults with Obesity in Small Wegovy Post Hoc Analysis

In a small Novo Nordisk analysis, 23 of 26 adults with obesity and excess liver fat reached normal levels on semaglutide. Here is what the numbers do and do not show.

Fortune · Oct 3

I'm an obesity expert and can't wait for the compounding craze to stop

If you can't name the medical reason your patient needs a knockoff GLP-1, you don't have one.

Medical Daily · Oct 3

Lilly's Foundayo Pill Linked to 57% Lower Predicted Diabetes Risk in ATTAIN-1 Modeling, but No Cases Were Counted

A Lilly-funded modeling analysis tied Foundayo to a 57% lower predicted 10-year diabetes risk. No actual diabetes cases were counted in the study.

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily · Oct 2

Patients Who Switched from Weight-Loss Shots to the Wegovy Pill Lost 4.1% of Body Weight in Three Months

Early real-world data show that 194 people who switched from GLP-1 shots to the Wegovy pill lost 4.1% of body weight in three months. Here's the catch.

Medical Daily · Oct 2

Experimental Survodutide Cut Weight Up to 13.1% in Adults with Type 2 Diabetes in Boehringer's Phase 3 Trial

Survodutide cut weight by up to 13.1% in adults with type 2 diabetes in a company-funded trial. It is not approved, and 18% quit due to side effects.

Medical Daily · Oct 1

Novo Nordisk Licenses Experimental Once-Weekly Obesity Pill From China's Hengrui in Deal Worth Up to $2.6 Billion

Novo Nordisk will pay $300 million upfront, and up to $2.6 billion in total, for Hengrui's once-weekly GLP-1/GIP pill, which has not been tested in people.

Times Life · Sep 30

6 Reasons Your Fitness Trackers Show Different Steps and Calorie Counts Every Day

1. Step-detection algorithms are not standardisedEvery tracker converts wrist movement into a step count using its own proprietary algorithm. Fitbit, Garmin, Apple Watch, and Mi Band each define a "step" differently at the code level, the minimum acceleration threshold, the cadence window, the filter that separates walking from hand gestures.…

The Independent UK · Sep 29

Breakthrough weight-loss drug helps diabetes patients lose a quarter of their body weight

Eli Lilly’s retatrutide works by imitating three separate hormones to manage appetite, blood sugar and metabolism

Medical Daily · Sep 29

Nearly Every Broken Thighbone Sends Fat into the Blood, but Weight May Help Decide Who Gets Sick

Fat enters the blood in most thighbone fractures but rarely causes illness. A finger-injury case adds to the evidence that obesity raises the risk.

Medical Daily · Sep 29

A Crushed Finger and Thumb Put a 43-Year-Old on a Ventilator as Fat Reached His Lungs

Hours after surgery on a crushed finger and thumb, a man's lungs began failing. Doctors found fat droplets in fluid washed from his airways.

1 2 3 4 5

Coverage From

People

Wes Streeting

3,072 stories

Tedros Adhanom Ghebreyesus

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.